Ratings on Nektar Therapeutics (NASDAQ: NKTR), Nps Pharmaceuticals Incorporated (NASDAQ: NPSP), Open Text (NASDAQ: OTEX), RightNow Technologies (NASDAQ: RNOW) and Rockwell Automation Inc (NYSE: ROK) reiterated by analysts.
Deutsche Bank (NYSE:DB) reiterated a “buy” rating on Nektar Therapeutics (NKTR). They have a price target of $14 on the company.
Brean Murray reiterated a “buy” rating on Nps Pharmaceuticals Incorporated (NPSP).
Raymond James (NYSE:RJF) reiterated an “outperform” rating on Open Text (OTEX).
Morgan Stanley (NYSE:MS) reiterated an “equal weight” rating on shares of RightNow Technologies (RNOW).
JPMorgan Chase & Co. (NYSE:JPM) reiterated a “neutral” rating on shares of Rockwell Automation Inc (ROK).
No comments:
Post a Comment